XORTX Therapeutics XRTX Stock
XORTX Therapeutics Price Chart
XORTX Therapeutics XRTX Financial and Trading Overview
| XORTX Therapeutics stock price | 2.5 USD |
| Previous Close | 0.65 USD |
| Open | 0.65 USD |
| Bid | 0 USD x 3000 |
| Ask | 0 USD x 1800 |
| Day's Range | 0.64 - 0.65 USD |
| 52 Week Range | 0.41 - 2.23 USD |
| Volume | 20.68K USD |
| Avg. Volume | 85.46K USD |
| Market Cap | 12.05M USD |
| Beta (5Y Monthly) | 0.175429 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.38 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.17 USD |
XRTX Valuation Measures
| Enterprise Value | 4.12M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.8422369 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.2700397 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.521 |
Trading Information
XORTX Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.175429 |
| 52-Week Change | -49.60% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.23 USD |
| 52 Week Low | 0.41 USD |
| 50-Day Moving Average | 0.69 USD |
| 200-Day Moving Average | 0.79 USD |
XRTX Share Statistics
| Avg. Volume (3 month) | 85.46K USD |
| Avg. Daily Volume (10-Days) | 23K USD |
| Shares Outstanding | 17.99M |
| Float | 16.41M |
| Short Ratio | 0.98 |
| % Held by Insiders | 3.22% |
| % Held by Institutions | 13.97% |
| Shares Short | 59.65K |
| Short % of Float | 0.33% |
| Short % of Shares Outstanding | 0.33% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -40.71% |
| Return on Equity (ttm) | -62.031% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -7893947 USD |
| Net Income Avi to Common (ttm) | -6138867 USD |
| Diluted EPS (ttm) | -0.42 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.91M USD |
| Total Cash Per Share (mrq) | 0.44 USD |
| Total Debt (mrq) | 61.54K USD |
| Total Debt/Equity (mrq) | 0.68 USD |
| Current Ratio (mrq) | 13.694 |
| Book Value Per Share (mrq) | 0.504 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8825760 USD |
| Levered Free Cash Flow (ttm) | -4071737 USD |
Profile of XORTX Therapeutics
| Country | United States |
| State | AB |
| City | Alberta Beach |
| Address | 3710 – 33rd Street NW |
| ZIP | T2L 2M1 |
| Phone | 403 455 7727 |
| Website | https://www.xortx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and acute kidney injury (AKI) associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. The company has a collaboration and license agreements with the Icahn School of Medicine to study the incidence of AKI and hyperuricemia in patients hospitalized with COVID-19; and with the University of Florida Research Foundation, Inc. XORTX Therapeutics Inc. is based in Alberta Beach, Canada.
Q&A For XORTX Therapeutics Stock
What is a current XRTX stock price?
XORTX Therapeutics XRTX stock price today per share is 2.5 USD.
How to purchase XORTX Therapeutics stock?
You can buy XRTX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for XORTX Therapeutics?
The stock symbol or ticker of XORTX Therapeutics is XRTX.
Which industry does the XORTX Therapeutics company belong to?
The XORTX Therapeutics industry is Biotechnology.
How many shares does XORTX Therapeutics have in circulation?
The max supply of XORTX Therapeutics shares is 2.92M.
What is XORTX Therapeutics Price to Earnings Ratio (PE Ratio)?
XORTX Therapeutics PE Ratio is now.
What was XORTX Therapeutics earnings per share over the trailing 12 months (TTM)?
XORTX Therapeutics EPS is -1.38 USD over the trailing 12 months.
Which sector does the XORTX Therapeutics company belong to?
The XORTX Therapeutics sector is Healthcare.
XORTX Therapeutics XRTX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16920.58 USD — |
-0.58
|
6.33B USD — | 16873.97 USD — | 16989.6 USD — | — - | 6.33B USD — |
- {{ link.label }} {{link}}